Gary Boddington Insider Profile
4 Followers
Gary Boddington, Director at RepliCel Life Sciences, holds 314.81K shares in RepliCel Life Sciences (Ticker: REPCF). Most recently, Gary Boddington Bought 214,815 shares of RepliCel Life Sciences on Jan 20, 2023 for an estimated value of $19.33K.
Gary Boddington's Trading History
| REPCFRepliCel Life Sciences | Jan 20, 2023 | Director | Informative Buy | 19.33K | ― | ||||||||||||||||||||||
REPCF Insider Shares: 314.81K (61.52%)
| |||||||||||||||||||||||||||
You May Also Like
Gary Boddington insider profile FAQ
What is the percentage of profitable transactions made by Gary Boddington?
The percentage of profitable transactions made by Gary Boddington is 0%.
What is the average return per transaction made by Gary Boddington?
The average return per transaction made by Gary Boddington is -40.50%.
What stocks does Gary Boddington hold?
Gary Boddington holds: REPCF stocks.
What was Gary Boddington’s latest transaction?
Gary Boddington’s latest transaction was an Informative Buy of $19.33K.
What was Gary Boddington's most profitable transaction?
Gary Boddington’s most profitable transaction was an Informative Buy of REPCF stock on January 20, 2023. The return on the trade was -35.70%.
What is Gary Boddington's role in RepliCel Life Sciences?
Gary Boddington's role in RepliCel Life Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
